tiprankstipranks
Cxapp Inc. (CXAI)
NASDAQ:CXAI
US Market
Want to see CXAI full AI Analyst Report?

CXApp (CXAI) AI Stock Analysis

533 Followers

Top Page

CXAI

CXApp

(NASDAQ:CXAI)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
$0.18
▼(-55.00% Downside)
Action:ReiteratedDate:04/14/26
The score is driven primarily by weak financial performance (large ongoing losses and cash burn with rising leverage) and bearish technicals (price below key moving averages with negative MACD). Earnings-call messaging and guidance provide some offset via improving margins, a shift to recurring revenue, and an optimistic 2026 growth outlook, but dilution and Nasdaq compliance events remain notable near-term risks.
Positive Factors
Recurring subscription revenue
A move to 98% subscription revenue materially improves revenue predictability and unit economics versus one‑time services. Durable recurring revenue supports higher retention, smoother cash inflows, and easier forecasting, enabling scalable sales motions and margin expansion as enterprise adoption grows.
Negative Factors
Material revenue decline
A 36% revenue contraction is a structural setback that undermines scale economics and makes fixed costs heavier per dollar of sales. Even if transition was intentional, sustained revenue shrinkage lengthens the pathway to profitable unit economics and raises execution risk for converting pipeline into higher recurring revenue.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring subscription revenue
A move to 98% subscription revenue materially improves revenue predictability and unit economics versus one‑time services. Durable recurring revenue supports higher retention, smoother cash inflows, and easier forecasting, enabling scalable sales motions and margin expansion as enterprise adoption grows.
Read all positive factors

CXApp (CXAI) vs. SPDR S&P 500 ETF (SPY)

CXApp Business Overview & Revenue Model

Company Description
CXApp Inc. provides a workplace experience platform for enterprise customers. It offers CXApp, a software-as-a-service platform with native mapping, analytics, on-device positioning, and applications technologies for use in various applications, s...
How the Company Makes Money
CXApp primarily makes money by selling enterprise software (SaaS) subscriptions and associated services tied to its workplace-experience platform. Key revenue streams typically include: (1) recurring subscription/license fees paid by enterprise cu...

CXApp Earnings Call Summary

Earnings Call Date:Mar 30, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 26, 2026
Earnings Call Sentiment Positive
The call communicated a transitional year (FY2025) marked by deliberate strategy changes: top-line revenue contracted materially as management exited lower-quality revenue and absorbed short-term transition costs, but underlying unit economics strengthened. Key positives include a sharp shift to recurring subscription revenue (98% of mix), gross margin expansion to 87%, an $11.1M cash balance providing runway, product differentiation via Agentic AI (BOND + CORTEX), solid IP filings, and a strategic TouchSource partnership and growing enterprise pipeline that underpin management’s expectation of double-digit growth in 2026. Main negatives are the 36% revenue decline, continued operating losses and negative adjusted EBITDA, non-cash accounting swings (derivative liabilities and goodwill impairment) that worsened adjusted results, customer churn during transition, and a NASDAQ bid-price compliance risk. On balance, the call emphasized that the difficult reset is largely complete and painted an optimistic growth outlook for 2026 while acknowledging near-term execution and market-compliance risks.
Positive Updates
Shift to High-Quality Recurring Revenue
Subscription revenue now represents 98% of total revenue, up from 87% a year ago (an 11 percentage-point increase), reflecting a deliberate move away from one-time services toward predictable, high-margin recurring revenue.
Negative Updates
Material Revenue Decline
Total revenue declined 36% year-over-year to $4.6M (from $7.2M), driven by the intentional exit of non-core contracts/professional services, customer churn during platform transition, and reduced bookings during repositioning.
Read all updates
Q4-2025 Updates
Negative
Shift to High-Quality Recurring Revenue
Subscription revenue now represents 98% of total revenue, up from 87% a year ago (an 11 percentage-point increase), reflecting a deliberate move away from one-time services toward predictable, high-margin recurring revenue.
Read all positive updates
Company Guidance
The company guided that 2026 will be a year of “AI‑driven acceleration,” targeting double‑digit revenue growth driven by its Agentic AI platform (BOND + CORTEX) and a 20+ customer pipeline, with strong Q4 bookings carrying into 2026; other metrics cited include FY2025 revenue of $4.6M (down 36% YoY from $7.2M) with subscription revenue now 98% of the mix (up from 87%), gross margin expanded to 87% (from 82%), cash of $11.1M (covering ~6 quarters), EBITDA loss improving to negative $10M (vs. negative $15.6M in 2024, a 35% improvement), adjusted EBITDA negative $9.8M (impacted by a -$4.5M fair‑value derivative swing vs. +$3.2M prior), cost of revenues down 55% to $578K (from $1.3M), OpEx $21.6M (+10% YoY) with R&D +4% and S&M cut 36%, and product/timing targets including CXAI 2.0 in June 2026, CXAI Sky roadmap thereafter, TouchSource channel access to 11,000+ screens, deployments across 200+ cities/50+ countries/1M+ users, 39 patents filed (18 granted), and a NASDAQ bid‑price compliance extension through September that management expects to cure via growth and market re‑rating.

CXApp Financial Statement Overview

Summary
Financials appear early-stage and strained: revenue is small and declined sharply in FY2025, losses remain very large relative to sales, and operating/free cash flow are persistently negative (continued reliance on external funding). The balance sheet still shows positive equity, but leverage increased meaningfully, raising funding/dilution risk if cash burn persists.
Income Statement
26
Negative
Balance Sheet
45
Neutral
Cash Flow
22
Negative
BreakdownDec 2025Mar 2025Mar 2024Dec 2022Dec 2021
Income Statement
Total Revenue4.58M7.14M7.37M8.47M0.00
Gross Profit1.27M5.86M5.62M6.41M0.00
EBITDA-12.27M-10.54M-53.58M-18.67M-1.50M
Net Income-13.47M-19.41M-53.62M-29.18M9.21M
Balance Sheet
Total Assets32.43M31.80M36.58M29.28M279.37M
Cash, Cash Equivalents and Short-Term Investments11.10M4.88M6.28M6.31M406.13K
Total Debt12.88M5.59M3.56M710.00K0.00
Total Liabilities18.45M16.21M11.18M5.89M21.70M
Stockholders Equity13.98M15.59M25.40M23.39M257.67M
Cash Flow
Free Cash Flow-10.38M-7.36M-17.98M-19.38M-595.32K
Operating Cash Flow-10.38M-7.33M-17.91M-18.89M-595.32K
Investing Cash Flow-23.00K-30.00K9.89M-482.00K0.00
Financing Cash Flow16.64M5.98M16.51M20.73M-17.58K

CXApp Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.40
Price Trends
50DMA
0.21
Negative
100DMA
0.28
Negative
200DMA
0.55
Negative
Market Momentum
MACD
-0.01
Positive
RSI
43.87
Neutral
STOCH
45.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CXAI, the sentiment is Negative. The current price of 0.4 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.21, and below the 200-day MA of 0.55, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.87 is Neutral, neither overbought nor oversold. The STOCH value of 45.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CXAI.

CXApp Risk Analysis

CXApp disclosed 55 risk factors in its most recent earnings report. CXApp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CXApp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
54
Neutral
$15.63M-3.51
47
Neutral
$17.99M-0.37-121.17%-24.08%70.11%
45
Neutral
$10.57M-0.35-91.15%-27.47%83.06%
45
Neutral
$9.95M-2.28-174.91%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CXAI
CXApp
0.18
-0.92
-83.73%
SMSI
Smith Micro Software
0.71
-0.21
-22.54%
IPM
Intelligent Protection Management
1.75
0.10
6.06%
AMST
Amesite
1.76
-0.34
-16.19%
WCT
Wellchange Holdings Company Limited
2.60
-11.28
-81.27%
NTCL
NetClass Technology Inc Class A
0.47
-10.77
-95.80%

CXApp Corporate Events

Private Placements and Financing
CXApp Raises Capital Through Unregistered Private Share Issuance
Neutral
Apr 10, 2026
CXApp Inc. issued a total of 4,116,659 shares of common stock to Avondale Capital, LLC under two pre-paid purchase arrangements tied to a March 26, 2025 securities purchase agreement. The shares were issued on March 30, 2026, April 1, 2026, April ...
Business Operations and StrategyPrivate Placements and Financing
CXApp Raises Private Capital via Unregistered Equity Issuance
Negative
Mar 26, 2026
CXApp Inc. issued an aggregate 10,028,891 shares of common stock to Avondale Capital, LLC under two pre-paid purchase arrangements linked to a March 26, 2025 securities purchase agreement. The stock was issued in a series of private transactions o...
Delistings and Listing ChangesRegulatory Filings and Compliance
CXApp Granted Extended Nasdaq Compliance Period Amid Delisting Risk
Negative
Mar 12, 2026
On September 11, 2025, CXApp Inc. was notified by Nasdaq that its common stock had traded below the $1.00 minimum bid price for 30 consecutive business days, triggering a 180‑day period, through March 10, 2026, to regain compliance. The comp...
Private Placements and Financing
CXApp Raises Capital Through Private Equity Share Issuance
Neutral
Jan 30, 2026
CXApp Inc. issued 4,616,481 shares of common stock to Avondale Capital, LLC under a March 26, 2025 pre-paid purchase arrangement established via a securities purchase agreement between the parties. The shares, priced at $0.24024 each, were issued ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 14, 2026